← Back to Search

Behavioural Intervention

Virtual Reality Distraction for Breastfeeding (VR-MOM Trial)

N/A

Waitlist Available

Led By Sylvie Le May, PhD

Research Sponsored by St. Justine's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Minimum 18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up it will be reported in percentage at the end of the study period (approx 1 year).

Awards & highlights

VR-MOM Trial Summary

This trial aims to assess the effects of using virtual reality (VR) on stress, discomfort, and volume of breast milk in mothers of premature newborns in the neonatal intensive care unit (NICU

Who is the study for?

This trial is for mothers with preterm newborns under 29 weeks old in a NICU at a Montreal pediatric center. They'll participate in the study for one week, using an electric breast pump to express milk. The goal is to recruit 30 mothers to account for potential dropouts.Check my eligibility

What is being tested?

The study tests if Virtual Reality (VR) can help reduce stress and discomfort while increasing the amount of milk expressed by these mothers. Each mother will experience two days with VR distraction and two days without, serving as their own control.See study design

What are the potential side effects?

Since this trial involves non-invasive VR technology, side effects are minimal but may include mild disorientation or motion sickness from the VR experience.

VR-MOM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am at least 18 years old.

VR-MOM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ it will be reported in percentage at the end of the study period (approx 1 year).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~it will be reported in percentage at the end of the study period (approx 1 year).

This trial's timeline: 3 weeks for screening, Varies for treatment, and it will be reported in percentage at the end of the study period (approx 1 year). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mothers' acceptability and satisfaction of VR

The feasibility of VR with healthcare professionals

Volume of milk expressed in a day

Secondary outcome measures

Discomfort during expression

Rate of participation

Recruitment rate

+2 more

VR-MOM Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Virtual Reality DistractionExperimental Treatment1 Intervention

Use of virtual reality (VR) during maternal milk expression.

Group II: Standard TreatmentActive Control1 Intervention

Mothers will express their maternal milk in a private room in the NICU with their baby or a photo of the baby.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Virtual Reality Distraction

2016

Completed Phase 3

~740

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

St. Justine's HospitalLead Sponsor

196 Previous Clinical Trials

79,009 Total Patients Enrolled

Sylvie Le May, PhDPrincipal InvestigatorSt. Justine's Hospital

13 Previous Clinical Trials

1,481 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to apply and participate in this ongoing research study?

"Based on the information provided by clinicaltrials.gov, this particular study is no longer actively seeking participants. The original posting date was on January 6th, 2024 and it was last updated on December 12th, 2023. However, there are currently a total of 427 ongoing clinical trials that are actively recruiting patients at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Virtual Reality Distraction for Maternal Milk Expression (PILOT)

Sylvie Le May 2024. "Virtual Reality Distraction for Maternal Milk Expression (PILOT)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06182449.